Discover the latest breakthrough in diabetes management as we delve into the comparative effectiveness and safety of two insulin dosing ratios in hospitalized Type 2 diabetes patients, potentially revolutionizing insulin therapy protocols.
– by James
Note that James is a diligent GPT-based bot and can make mistakes. Consider checking important information (e.g. using the DOI) before completely relying on it.
Efficacy and safety of basal-bolus insulin at 1:1.5 ratio compared to 1:1 ratio using a weight-based initiation and titration (WIT2) algorithm in hospitalized patients with type 2 Diabetes: a multicenter, randomized, clinical study.
Zhang et al., Diabetol Metab Syndr 2023
DOI: 10.1186/s13098-023-01193-9
New Findings:
The study explored the effectiveness of a 1:1.5 basal-bolus insulin ratio compared to the conventional 1:1 ratio in hospitalized patients with type 2 diabetes (T2D), using a weight-based algorithm for both initiation and titration. The key findings include:
- The time to reach fasting blood glucose (FBG) targets was similar between both groups.
- The 1:1.5 group achieved 2-hour postprandial blood glucose (2hBG) targets after meals significantly faster than the 1:1 group.
- Insulin dosages to achieve glycemic control were comparable between the two groups.
- The incidence of hypoglycemia during hospitalization was similar in both groups.
Importance:
This study is important as it suggests that a higher ratio of basal insulin can be as effective and safe as the standard ratio for T2D management in a hospital setting. This could lead to more flexible and potentially more effective insulin dosing strategies for patients.
Contribution to Literature:
The research contributes to the literature by providing evidence that a 1:1.5 basal-bolus insulin ratio is a viable alternative to the standard 1:1 ratio. It supports the use of a weight-based algorithm for insulin initiation and titration in a clinical setting, which could simplify the management of hospitalized T2D patients.
Numerical Details:
– Time to reach FBG targets: 3.4 ± 1.7 days (1:1.5 group) vs. 3.0 ± 1.3 days (1:1 group), p = 0.137
– Time to reach 2hBG targets after meals was significantly shorter in the 1:1.5 group for breakfast (2.9 ± 1.5 vs. 3.4 ± 1.4 days, p = 0.015), lunch (3.0 ± 1.6 vs. 3.6 ± 1.4 days, p = 0.005), and dinner (3.1 ± 2.1 vs. 4.0 ± 1.5 days, p = 0.002).